A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Denosumab in Pediatric Subjects With Glucocorticoid-induced Osteoporosis

Recruiting
5 years - 17 years
All
1 Location

Brief description of study

We are doing this research study because we are trying to learn more about a drug called Denosumab in children with glucocorticoid-induced osteoporosis.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Glucocorticoid-induced Osteoporosis
  • Age: 5 years - 17 years
  • Gender: All

Inclusion Criteria

Clinical diagnosis of GiOP

Other criteria exists-please contact study team

Updated on 04 Aug 2024. Study ID: 1809456517

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Zip Code
Please provide your 5-digit zip code
0 0 /250
Other language

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team